Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Capital Reinvestment Ratio
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Capital Reinvestment Ratio of 0.77x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥89.33 Million) in capital expenditures (CN¥68.55 Million). Check 301263 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangdong Taienkang Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2019–2024)
This chart tracks Guangdong Taienkang Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see 301263 cash generation efficiency.
Annual Capital Reinvestment Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Year-by-year Capital Reinvestment Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2024. See Guangdong Taienkang Pharmaceutical Co. L free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.77x | CN¥89.33 Million | CN¥68.55 Million | ▼ -64.1% |
| 2023 | 2.14x | CN¥93.53 Million | CN¥200.01 Million | ▲ +254.1% |
| 2022 | 0.60x | CN¥148.81 Million | CN¥89.88 Million | ▲ +62.4% |
| 2021 | 0.37x | CN¥120.02 Million | CN¥44.65 Million | ▼ -49.9% |
| 2020 | 0.74x | CN¥125.53 Million | CN¥93.12 Million | ▲ +533.5% |
| 2019 | 0.12x | CN¥75.44 Million | CN¥8.83 Million | — |